HDAC9 and breast cancer: Following the discovery of HDACs in 1996 [59], the HDAC inhibitors that followed were found to attenuate cell proliferation, induce differentiation of both normal and breast cancer cell lines, and regulate expression of cell cycle genes [60–62].